Korin Miller
- Indexed articles, last 90 days
- 4
- Latest publication
- Sep 18, 2026
- Outlet visibility, for Allure
- Top 100K sites
- Earliest in this view
- Aug 5, 2026
Latest articles
Can Carbs Lower Your Biological Age? A New Study Suggests They Might (opens the original)
Read excerpt
Some of nutrition’s most reviled macronutrients might be getting an image overhaul, courtesy of a new study. The research, which was conducted by the University of Sydney and ran in the journal Aging Cell, sought to find how much of an impact changing eating habits could have on a person’s biological age. While there is no standardized way to measure biological age, this study looked at, among other things insulin, blood pressure, cholesterol, and more to determine the age of the subjects’ cells
Acupuncture Could Be Helpful for Depression, New Study Shows (opens the original)
Read excerpt
It’s one more tool to consider, according to doctors.
Medical Pros Weigh in on Neko Health, the Full-Body Health Scan Coming to the US (opens the original)
Read excerpt
Commercial full-body scans are all over your social feeds. They’ve been plugged by Kim Kardashian, Kate Hudson, Cindy Crawford, and more, but it’s hard to deny that they come with a hefty price tag. Now, a new company is debuting in the US, and its scan is a fraction of the cost of the competition. The company, Neko Health, is launching in New York City after having multiple locations in Sweden and the UK. Neko Health’s signature scan will be $499. By comparison, a scan from celebrity-endorsed P
The Risk of Hair Loss May Be "Significantly Greater" With This GLP-1 Drug Than With Others (opens the original)
Read excerpt
Hair loss can be sparked by everything from your genetics to your stress levels, making it hard at times to pinpoint what’s fueling the shedding. But new research suggests that, if you’re suddenly losing hair, you might want to take a closer look at your GLP-1. The study, which hasn’t been published in a medical journal yet, found that the risk of developing hair loss was "significantly greater” when people started using tirzepatide (Zepbound, Mounjaro) over fellow GLP-1 medication semaglutide (
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 100K sites
For Allure, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.